AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

May 1, 2013

Primary Completion Date

September 6, 2016

Study Completion Date

September 6, 2016

Conditions
Traumatic Shock
Interventions
DRUG

Vasopressin

After receiving greater than 6 units of blood product within the first 12 hours of admission, trauma patients will be randomized to either normal saline or vasopressin. Subjects will receive an initial 4 unit bolus followed by an infusion of 0 to 0.04 units titrated to maintain a mean arterial blood pressure of equal to or greater than 65 mmHg for a total of 48 hours.

Trial Locations (1)

19104

Hospital at the Unversity of Pennyslvania, Philadelphia

Sponsors
All Listed Sponsors
collaborator

National Trauma Research Institute

OTHER

collaborator

United States Department of Defense

FED

lead

University of Pennsylvania

OTHER